SARS, Spike Protein, Middle (SARS) SARS Associated Coronavirus Recombinant Protein

Contains a mosaic of the immunodominant regions of themiddle region of the Spike protein. Not full-length spike protein. Contains GST fusion partner. Immunoreactive with SARS positive sera.

A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximately 27 to 31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139kD protein and the major surface antigen of the virus, to the angiotensin converting enzyme 2 (ACE2) on target cells.

Small volumes of SARS, Spike Protein, Middle recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS637618 is a recombinant protein targeting SARS, Spike Protein, Middle. Also known as SARS, Spike Protein, Middle, Recombinant (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus). Host: E Coli.